Solutions
00
Overview
01
Clinical Diagnostics
02
Life Sciences
About
Team
News
Career
Contact
Menu
News
Latest news
More
Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow
04 April, 2022
By Patrick de Boer
LUMO Labs leads pre-seed round in Aiosyn’s AI-powered diagnostics platform
03 February, 2022
By Patrick de Boer
Investering in Aiosyns AI-platform voor efficiënte en precieze diagnose
03 February, 2022
By Patrick de Boer
Aiosyn was awarded a NWO Take-off Phase 2 project
22 December, 2021
By Wouter Bulten
Aiosyn receives a PPP project to improve breast and prostate cancer grading
23 November, 2021
By Jeroen van der Laak
More
Publications
More
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Nature Medicine
13 January, 2022
Deep learning in histopathology: the path to the clinics – invited review
Nature Medicine
14 May, 2021
Deep learning enables fully automated mitotic density assessment in breast cancer histopathology
European Journal of Cancer
1 October, 2020
Artificial Intelligence Assistance Significantly Improves Gleason Grading of Prostate Biopsies by Pathologists
Modern pathology
5 August, 2020
Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study
The Lancet Oncology
1 February, 2020
More